URINARY INTERLEUKIN-8 AND 18 PREDICT THE RESPONSE OF SUPERFICIAL BLADDER CANCER TO INTRAVESICAL THERAPY WITH BACILLUS CALMETTE-GUERIN-Reference-Cited by-同舟云学术

URINARY INTERLEUKIN-8 AND 18 PREDICT THE RESPONSE OF SUPERFICIAL BLADDER CANCER TO INTRAVESICAL THERAPY WITH BACILLUS CALMETTE-GUERIN

Published:2000-12 Issue:6 Volume:164 Page:2129-2133
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

THALMANN GEORGE N.¹,SERMIER ALAIN¹,RENTSCH CYRILL¹,MÖHRLE KARIN¹,CECCHINI MARCO G.¹,STUDER URS E.¹

Affiliation:

1. From the Department of Urology and Gene Therapy Laboratory, Department of Clinical Research, University of Berne, Berne, Switzerland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference22 articles.

1. Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS);Smith;J Urol,1999

2. Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy;Böhle;J Urol,1990

3. Neutrophil-activating peptide-1/interleukin-8 detection in human urine during acute bladder inflammation caused by transurethral resection of superficial cancer and bacillus Calmette-Guerin;Bettex-Galland;Eur Urol,1991

4. BCG treatment and the importance of an inflammatory response;Schamhart;Urol Res,1992

5. Interleukin-4 (IL-4), interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor (TNF), tumor necrosis factor receptors (TNFR) 55 and 75 after instillations with Bacillus Calmette-Guerin (BCG) in patients with superficial bladder cancer;Thalmann;J Urol,1993

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Awareness of intratumoral bacteria and their potential application in cancer treatment;Discover Oncology;2023-05-06

2. Laboratory predictors to intravesical BCG therapy response in patients with non-muscle invasive bladder cancer;Urology Herald;2022-12-26

3. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape;Société Internationale d’Urologie Journal;2022-07-15

4. Nonmuscle-invasive bladder cancer, old problems, new insights;Current Opinion in Urology;2022-07

5. Immune mechanisms and molecular therapeutic strategies to enhance immunotherapy in non–muscle invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2022-07